The SOL Capital Management CO Reduced the position of Becton Dickinson and Co. (BDX)

The SOL Capital Management CO Reduced the position of Becton Dickinson and Co. (BDX)

SOL Capital Management CO decreased its position in Becton Dickinson and Co. (NYSE:BDX) by 1.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 4,397 shares of the company’s stock after selling 50 shares during the period. SOL Capital Management CO’s holdings in Becton Dickinson and were worth $746,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Hartford Investment Management Co. increased its position in shares of Becton Dickinson and by 0.9% in the second quarter. Hartford Investment Management Co. now owns 60,471 shares of the company’s stock worth $10,255,000 after buying an additional 563 shares during the last quarter. Cullen Frost Bankers Inc. raised its position in shares of Becton Dickinson and by 0.4% in the second quarter. Cullen Frost Bankers Inc. now owns 84,551 shares of the company’s stock worth $14,339,000 after buying an additional 356 shares during the period. Confluence Investment Management LLC raised its position in shares of Becton Dickinson and by 4.2% in the second quarter. Confluence Investment Management LLC now owns 67,819 shares of the company’s stock worth $11,501,000 after buying an additional 2,715 shares during the period. Strs Ohio raised its position in shares of Becton Dickinson and by 1.0% in the second quarter. Strs Ohio now owns 134,290 shares of the company’s stock worth $22,774,000 after buying an additional 1,379 shares during the period. Finally, Trust Co. of Vermont raised its position in shares of Becton Dickinson and by 1.7% in the second quarter. Trust Co. of Vermont now owns 37,729 shares of the company’s stock worth $6,398,000 after buying an additional 631 shares during the period. Hedge funds and other institutional investors own 81.85% of the company’s stock.

Becton Dickinson and Co. (NYSE:BDX) traded down 0.23% on Monday, reaching $171.54. The company had a trading volume of 803,993 shares. Becton Dickinson and Co. has a 12 month low of $129.50 and a 12 month high of $181.76. The stock has a market capitalization of $36.53 billion, a price-to-earnings ratio of 32.74 and a beta of 0.93. The firm has a 50 day moving average price of $176.40 and a 200-day moving average price of $169.65.

Becton Dickinson and (NYSE:BDX) last announced its quarterly earnings data on Thursday, August 4th. The company reported $2.35 EPS for the quarter, beating the Zacks’ consensus estimate of $2.21 by $0.14. The firm had revenue of $3.20 billion for the quarter, compared to analyst estimates of $3.21 billion. Becton Dickinson and had a return on equity of 24.26% and a net margin of 9.24%. The business’s quarterly revenue was up 2.5% compared to the same quarter last year. During the same period last year, the company earned $2.05 EPS. Analysts forecast that Becton Dickinson and Co. will post $8.56 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, September 30th. Shareholders of record on Friday, September 9th were given a $0.66 dividend. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.64 dividend on an annualized basis and a yield of 1.54%. Becton Dickinson and’s payout ratio is 50.19%.

A number of research analysts have issued reports on BDX shares. Jefferies Group reiterated a “buy” rating on shares of Becton Dickinson and in a research report on Friday, August 5th. Bank of America Corp. reiterated a “buy” rating on shares of Becton Dickinson and in a research report on Tuesday, July 12th. Leerink Swann reiterated a “hold” rating on shares of Becton Dickinson and in a research report on Tuesday, August 9th. Zacks Investment Research lowered Becton Dickinson and from a “buy” rating to a “hold” rating in a research report on Wednesday, July 13th. Finally, Cowen and Company reiterated an “outperform” rating and set a $185.00 price target on shares of Becton Dickinson and in a research report on Tuesday, August 16th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating, eight have given a buy rating and two have given a strong buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $170.82.

In other news, insider Gary M. Cohen sold 29,367 shares of the firm’s stock in a transaction on Thursday, August 11th. The stock was sold at an average price of $176.81, for a total value of $5,192,379.27. Following the transaction, the insider now directly owns 125,870 shares in the company, valued at approximately $22,255,074.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Linda M. Tharby sold 11,704 shares of the firm’s stock in a transaction on Tuesday, September 6th. The stock was sold at an average price of $177.27, for a total value of $2,074,768.08. Following the completion of the transaction, the insider now owns 22,146 shares in the company, valued at $3,925,821.42. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

Becton Dickinson and Company Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Related posts

Leave a Comment